drugset / Trial / NCT01565343

A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers

NCT01565343

Phase 1 Completed 25 enrolled Avid Radiopharmaceuticals
Non-randomizedSingle-groupSingle-blindDiagnostic

Summary

This study will test if two AV-45 PET scans up to 4 weeks apart in AD subjects and healthy volunteers provide the same results. The study will also test two different AV-45 injection methods in a small subgroup of enrolled AD subjects (slow vs. fast bolus group).

Timeline

Start
2008-04
Primary completion
2009-04
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject florbetapir F 18 Diagnostic / imaging agent 370 mbq Intravenous

Indications